ARCHIVES

Emphasis On Early Disease In Clinical Trials, Early Lung Cancer Detection Seen As “Landmark”

This article is from The Cancer Letter archive.

Vol. 01 No. 38 | September 19, 1975

Download PDF Visit The Full Archive

Related Articles

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

June 29, 2001

Cancer Leadership Council letter calls for permanent leadership of NCI and FDA.

November 23, 2005

High Risk Youth Targeted In Concept Ok’d By Advisors

February 8, 1991

In Brief: MD Anderson’s DuBois Named head of Arizona State’s Biodesign Institute

October 5, 2012

Cooperative Groups: Insurers Agree To Cover Patient Care Costs In Group Trials

September 26, 1997

Institute of Medicine Elects 70 Members at Annual Meeting

October 25, 2013